VanEck Associates’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $275K | Buy |
25,243
+3,639
| +17% | +$45.5K | ﹤0.01% | 1238 |
|
|
2025
Q4 | $279K | Buy |
21,604
+364
| +2% | +$4.67K | ﹤0.01% | 1254 |
|
|
2025
Q3 | $274K | Sell |
21,240
-1,374
| -6% | -$18.4K | ﹤0.01% | 1255 |
|
|
2025
Q2 | $403K | Buy |
22,614
+230
| +1% | +$4.01K | ﹤0.01% | 1183 |
|
|
2025
Q1 | $399K | Buy |
22,384
+1,325
| +6% | +$30.1K | ﹤0.01% | 1170 |
|
|
2024
Q4 | $628K | Sell |
21,059
-3,185
| -13% | -$67.4K | ﹤0.01% | 1108 |
|
|
2024
Q3 | $392K | Buy |
24,244
+376
| +2% | +$6.82K | ﹤0.01% | 1117 |
|
|
2024
Q2 | $409K | Buy |
23,868
+8,094
| +51% | +$142K | ﹤0.01% | 1112 |
|
|
2024
Q1 | $247K | Buy |
15,774
+706
| +5% | +$10.4K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $225K | Sell |
15,068
-5
| -0% | -$67 | ﹤0.01% | 1154 |
|
|
2023
Q3 | $243K | Buy |
15,073
+959
| +7% | +$27.6K | ﹤0.01% | 1129 |
|
|
2023
Q2 | $586K | Sell |
14,114
-2,037
| -13% | -$126K | ﹤0.01% | 1004 |
|
|
2023
Q1 | $971K | Sell |
16,151
-226
| -1% | -$18.1K | ﹤0.01% | 841 |
|
|
2022
Q4 | $1.2M | Buy |
16,377
+2,845
| +21% | +$214K | ﹤0.01% | 770 |
|
|
2022
Q3 | $1.03M | Buy |
13,532
+46
| +0.3% | +$3.59K | ﹤0.01% | 763 |
|
|
2022
Q2 | $937K | Sell |
13,486
-4,661
| -26% | -$351K | ﹤0.01% | 802 |
|
|
2022
Q1 | $1.5M | Buy |
18,147
+101
| +0.6% | +$7.44K | ﹤0.01% | 762 |
|
|
2021
Q4 | $1.35M | Sell |
18,046
-1,059
| -6% | -$106K | ﹤0.01% | 792 |
|
|
2021
Q3 | $2.22M | Sell |
19,105
-1,533
| -7% | -$232K | 0.01% | 652 |
|
|
2021
Q2 | $4.58M | Buy |
20,638
+1,555
| +8% | +$302K | 0.01% | 479 |
|
|
2021
Q1 | $2.52M | Buy |
19,083
+281
| +1% | +$44.5K | 0.01% | 559 |
|
|
2020
Q4 | $3.25M | Sell |
18,802
-9,912
| -35% | -$1.36M | 0.01% | 456 |
|
|
2020
Q3 | $3.2M | Buy |
28,714
+598
| +2% | +$47.8K | 0.01% | 399 |
|
|
2020
Q2 | $1.67M | Buy |
28,116
+243
| +0.9% | +$16K | 0.01% | 518 |
|
|
2020
Q1 | $1.88M | Buy |
27,873
+953
| +4% | +$75.3K | 0.01% | 465 |
|
|
2019
Q4 | $2.27M | Buy |
26,920
+830
| +3% | +$67K | 0.01% | 500 |
|
|
2019
Q3 | $1.95M | Buy |
26,090
+88
| +0.3% | +$7.04K | 0.01% | 481 |
|
|
2019
Q2 | $1.64M | Buy |
26,002
+3,111
| +14% | +$158K | 0.01% | 494 |
|
|
2019
Q1 | $1.1M | Buy |
22,891
+532
| +2% | +$25.6K | 0.01% | 561 |
|
|
2018
Q4 | $749K | Buy |
22,359
+3,345
| +18% | +$122K | ﹤0.01% | 586 |
|
|
2018
Q3 | $996K | Buy |
19,014
+1,089
| +6% | +$43.3K | ﹤0.01% | 556 |
|
|
2018
Q2 | $561K | Sell |
17,925
-1,227
| -6% | -$34.1K | ﹤0.01% | 661 |
|
|
2018
Q1 | $418K | Buy |
19,152
+1,278
| +7% | +$27.5K | ﹤0.01% | 587 |
|
|
2017
Q4 | $361K | Sell |
17,874
-1,350
| -7% | -$26K | ﹤0.01% | 593 |
|
|
2017
Q3 | $382K | Buy |
19,224
+858
| +5% | +$16.9K | ﹤0.01% | 590 |
|
|
2017
Q2 | $318K | Buy |
+18,366
| New | +$237K | ﹤0.01% | 605 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM